Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
165.14
-2.20 (-1.31%)
Jan 28, 2026, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.19 billion as of January 28, 2026. Its market cap has increased by 261.11% in one year.
Market Cap
6.19B
Enterprise Value
5.98B
1-Year Change
261.11%
Ranking
Category
Stock Price
$165.14
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.19B, an increase of 4,178.43%. That is a compound annual growth rate of 172.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 6.28B | 4.61% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxcyte | 7.11B |
| Rhythm Pharmaceuticals | 7.04B |
| Structure Therapeutics | 6.19B |
| PTC Therapeutics | 6.06B |
| Mirum Pharmaceuticals | 5.94B |
| ImmunityBio | 5.86B |
| Cogent Biosciences | 5.86B |
| Kymera Therapeutics | 5.77B |